LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 82 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $72,016,000 | -31.8% | 11,200 | 0.0% | 0.00% | – |
| Q4 2018 | $105,616,000 | -53.2% | 11,200 | 0.0% | 0.00% | – |
| Q3 2018 | $225,456,000 | -60.8% | 11,200 | -43.2% | 0.00% | – |
| Q2 2018 | $575,349,000 | +171.2% | 19,724 | +223.3% | 0.00% | – |
| Q3 2017 | $212,158,000 | – | 6,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 4,138,893 | $123,256,000 | 18.11% |
| Broadfin Capital, LLC | 1,656,720 | $49,337,000 | 7.69% |
| SECTORAL ASSET MANAGEMENT INC | 1,128,219 | $33,598,000 | 3.68% |
| Perceptive Advisors | 4,313,611 | $128,459,000 | 3.60% |
| RTW INVESTMENTS, LP | 1,122,540 | $33,429,000 | 3.18% |
| Asymmetry Capital Management, L.P. | 55,864 | $1,664,000 | 2.08% |
| EMORY UNIVERSITY | 77,335 | $2,303,000 | 1.64% |
| Monashee Investment Management LLC | 185,000 | $5,509,000 | 1.52% |
| SPHERA FUNDS MANAGEMENT LTD. | 260,000 | $7,743,000 | 1.18% |
| Stanley-Laman Group, Ltd. | 167,825 | $4,998,000 | 1.14% |